ENDODERM
ActiveSummary
ENDODERM has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €518,959 and a net result of €199,187. Equity is growing by ~15.6% per year across the filed fiscal years. Its solvency ranks better than 40% of 644 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability93▲+11
Solvency68▼-18
Growth68▲+21
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40,000 at 30 days acceptable
Liquidity ample (current ratio 2.18 against 15.56 in 2024; short-term debt: 25.9% and cash: 37.8% of total assets), but 56.6% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
43.4%
Return on assets
16.6%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
8 d early
2024
3 d early
2023
5 d late
2022
16 d late
2021
23 d early
2020
44 d early
2019
47 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 15 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
In the rankings
#4 company by total assets in Pont-à-Celles, Health and social work sector#6 company by equity in Pont-à-Celles, Health and social work sector
Turnover
€744,092▲ 27.7%
2024 · €582,831
EBIT margin
40.9%▲ 27.6pp
2024 · 13.3%
Net result
€199,187▲ 391%
2024 · €40,577
Working capital
€366,374▼ 35.1%
2024 · €564,398
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Turnover€598,187▼ 0.5%€646,286▲ 8.0%€524,749▼ 18.8%€582,831▲ 11.1%€744,092▲ 27.7%
Operating result€217,562▼ 13.8%€244,581▲ 12.4%€120,724▼ 50.6%€77,561▼ 35.8%€304,461▲ 293%
Net result€139,187within the sector's middle half▼ 16.0%€160,379above the sector's middle half▲ 15.2%€79,253within the sector's middle half▼ 50.6%€40,577within the sector's middle half▼ 48.8%€199,187within the sector's middle half▲ 391%
EBIT margin36.4%▼ 5.6pp37.8%▲ 1.5pp23.0%▼ 14.8pp13.3%▼ 9.7pp40.9%▲ 27.6pp
Equity€604,802within the sector's middle half▲ 29.9%€739,934above the sector's middle half▲ 22.3%€779,187within the sector's middle half▲ 5.3%€678,966within the sector's middle half▼ 12.9%€518,959within the sector's middle half▼ 23.6%
Total assets€805,273within the sector's middle half▲ 11.9%€944,615within the sector's middle half▲ 17.3%€961,296within the sector's middle half▲ 1.8%€1.1mwithin the sector's middle half▲ 15.1%€1.2mwithin the sector's middle half▲ 8.1%
Debt€200,472▼ 21.1%€204,681▲ 2.1%€182,108▼ 11.0%€427,417▲ 135%€677,461▲ 58.5%
Working capital€523,970above the sector's middle half▲ 63.5%€659,203above the sector's middle half▲ 25.8%€704,734above the sector's middle half▲ 6.9%€564,398above the sector's middle half▼ 19.9%€366,374within the sector's middle half▼ 35.1%
Solvency75.1%within the sector's middle half▲ 10.4pp78.3%above the sector's middle half▲ 3.2pp81.1%above the sector's middle half▲ 2.7pp61.4%within the sector's middle half▼ 19.7pp43.4%within the sector's middle half▼ 18.0pp
Current ratio9.60above the sector's middle half▲ 6.479.72above the sector's middle half▲ 0.1212.87above the sector's middle half▲ 3.1615.56above the sector's middle half▲ 2.682.18within the sector's middle half▼ 13.37
Return on assets (ROA)17.3%within the sector's middle half▼ 5.7pp17.0%within the sector's middle half▼ 0.3pp8.2%within the sector's middle half▼ 8.7pp3.7%within the sector's middle half▼ 4.6pp16.6%within the sector's middle half▲ 13.0pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 293% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.2m
Fixed assets
€520,769 ▲ 3.5%
Current assets
€675,652 ▲ 12.0%
Equity and liabilities €1.2m
Equity
€518,959 ▼ 23.6%
Debt
€677,461 ▲ 58.5%
Debt's share of the balance-sheet total rises from 38.6% to 56.6%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€351,789▲
2024 · €129,704
Cash flow
€246,515▲
2024 · €92,720
Debt to equity
1.31▲
2024 · 0.63
ROE
38.4%▲
2024 · 6.0%
Interest coverage
10.82▲
2024 · 6.78
Debt ≤ 1 year
€309,278▲
2024 · €38,766
Debt > 1 year
€368,184▼
2024 · €388,651
Income taxes
€72,763▲
2024 · €17,863
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 17,810 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 97% are still going.
- Small
- 10 to 20 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.2%
went bankrupt
3.1%
stopped otherwise
97%
still going
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 17,810 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Turnover70 | €598,187 | €646,286 | €524,749 | €582,831 | €744,092 | ▲ 27.7% |
| Goods, raw materials, services and sundry goods60/61 | €399,424 | €421,014 | €358,370 | €477,850 | €412,058 | ▼ 13.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €34,836 | €37,849 | €43,092 | €52,143 | €47,328 | ▼ 9.2% |
| Other operating charges640/8 | €8,368 | €6,716 | €8,947 | €2,623 | €3,142 | ▲ 19.8% |
| Gross operating margin9900 | €260,767 | €289,147 | €172,763 | €132,327 | €354,931 | ▲ 168% |
| Operating profit (loss)9901 | €217,562 | €244,581 | €120,724 | €77,561 | €304,461 | ▲ 293% |
| Financial income75/76B | €1 | - | €0 | €13 | - | - |
| Recurring financial income75 | €1 | - | €0 | €13 | - | - |
| Financial charges65/66B | €9,951 | €6,429 | €5,977 | €19,134 | €32,510 | ▲ 69.9% |
| Recurring financial charges65 | €9,951 | €6,429 | €5,977 | €19,134 | €32,510 | ▲ 69.9% |
| Profit (loss) for the period before taxes9903 | €207,612 | €238,152 | €114,747 | €58,440 | €271,951 | ▲ 365% |
| Income taxes67/77 | €68,425 | €77,773 | €35,494 | €17,863 | €72,763 | ▲ 307% |
| Profit (loss) for the period9904 | €139,187 | €160,379 | €79,253 | €40,577 | €199,187 | ▲ 391% |
| Profit (loss) for the period to be appropriated9905 | €139,187 | €160,379 | €79,253 | €40,577 | €199,187 | ▲ 391% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €805,273 | €944,615 | €961,296 | €1.1m | €1.2m | ▲ 8.1% |
| Formation expenses20 | €0 | €0 | €0 | €0 | €0 | - |
| Fixed assets21/28 | €220,363 | €209,804 | €197,212 | €503,220 | €520,769 | ▲ 3.5% |
| Intangible fixed assets21 | €48,000 | €36,000 | €24,000 | €12,000 | €0 | ▼ 100% |
| Tangible fixed assets22/27 | €172,363 | €173,804 | €173,212 | €491,220 | €520,769 | ▲ 6.0% |
| Land and buildings22 | €122,643 | €112,909 | €103,176 | €421,130 | €411,173 | ▼ 2.4% |
| Plant, machinery and equipment23 | €47,556 | €48,534 | €36,918 | €21,836 | €77,908 | ▲ 257% |
| Furniture and vehicles24 | €2,164 | €12,361 | €33,119 | €48,254 | €31,688 | ▼ 34.3% |
| Current assets29/58 | €584,910 | €734,810 | €764,083 | €603,163 | €675,652 | ▲ 12.0% |
| Amounts receivable within one year40/41 | €2,047 | €49,077 | €24,466 | €131,395 | €27,237 | ▼ 79.3% |
| Trade receivables40 | €0 | €5,000 | €0 | €0 | €0 | - |
| Other amounts receivable41 | €2,047 | €44,077 | €24,466 | €131,395 | €27,237 | ▼ 79.3% |
| Current investments50/53 | - | €30,001 | €30,001 | €45,001 | €62,461 | ▲ 38.8% |
| Cash at bank and in hand54/58 | €522,735 | €583,759 | €621,630 | €392,747 | €451,957 | ▲ 15.1% |
| Deferred charges and accrued income490/1 | €60,129 | €71,974 | €87,986 | €34,020 | €133,997 | ▲ 294% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €805,273 | €944,615 | €961,296 | €1.1m | €1.2m | ▲ 8.1% |
| Equity10/15 | €604,802 | €739,934 | €779,187 | €678,966 | €518,959 | ▼ 23.6% |
| Contributions10/11 | €6,200 | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Capital10 | €6,200 | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Issued capital100 | €18,600 | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Uncalled capital101 | €12,400 | €0 | - | - | - | - |
| Reserves13 | €598,602 | €721,334 | €760,587 | €619,789 | €301,172 | ▼ 51.4% |
| Distributable reserves133 | €598,602 | €721,334 | €760,587 | €619,789 | €301,172 | ▼ 51.4% |
| Profit (loss) carried forward14 | - | - | - | €40,577 | €199,187 | ▲ 391% |
| Amounts payable17/49 | €200,472 | €204,681 | €182,108 | €427,417 | €677,461 | ▲ 58.5% |
| Amounts payable after more than one year17 | €139,531 | €129,073 | €122,759 | €388,651 | €368,184 | ▼ 5.3% |
| Financial debts170/4 | €139,531 | €129,073 | €122,759 | €388,651 | €368,184 | ▼ 5.3% |
| Amounts payable within one year42/48 | €60,940 | €75,607 | €59,349 | €38,766 | €309,278 | ▲ 698% |
| Current portion of amounts payable after more than one year42 | €20,216 | €23,471 | €0 | €19,963 | €81,364 | ▲ 308% |
| Trade debts44 | €1,566 | €3,786 | €0 | €1,303 | €1,166 | ▼ 10.5% |
| Suppliers440/4 | €1,566 | €3,786 | €0 | €1,303 | €1,166 | ▼ 10.5% |
| Taxes, remuneration and social security45 | €16,000 | €16,350 | €16,663 | €17,500 | €8,000 | ▼ 54.3% |
| Taxes450/3 | €8,000 | €16,350 | €16,663 | €14,000 | €8,000 | ▼ 42.9% |
| Remuneration and social security454/9 | €8,000 | €0 | €0 | €3,500 | €0 | ▼ 100% |
| Other amounts payable47/48 | €23,159 | €32,000 | €42,686 | €0 | €218,748 | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €139,187 | €160,379 | €79,253 | €40,577 | €199,187 | ▲ 391% |
| + Depreciation and write-downs630 | €34,836 | €37,849 | €43,092 | €52,143 | €47,328 | ▼ 9.2% |
| Operating cash flow (approximation) | €174,023 | €198,229 | €122,345 | €92,720 | €246,515 | ▲ 166% |
| Investment in fixed assets (approximation) | - | -€27,290 | -€30,500 | -€358,150 | -€64,877 | ▲ 81.9% |
| Change in cash | - | €61,024 | €37,871 | -€228,883 | €59,210 | ▲ 126% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
23-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
31-12
Financial
Highest result since 2018net €199,187 ▲391%
Operating result €304,461, net result €199,187, both a record.
28-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Weakest financial yearnet €40,577 ▼48.8%
Net result drops to €40,577, the lowest in the series; recovery starts the following year.
05-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 5 days late
2023
16-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 16 days late
2022
08-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial
Liquidity triplescurrent ratio 9.60
Current ratio from 3.12 to 9.60; short-term debt falls from €150,909 to €60,940.
31-12
Financial
Equity above €500,000Eq €604,802 ▲29.9%
4 profitable years in a row build equity to €604,802.
17-06
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
14-06
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
31-12
Financial
Equity above €200,000Eq €299,891 ▲104%
2 profitable years in a row build equity to €299,891.
Show earlier events
07-06
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
21-06
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
13-07
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Pont-à-Celles · 1 establishment unit since 2016
Ground area
109 m²
Building footprint
114 m²
Parcel 52051A0624/00L000, Wallonia. Linked by address, not a title deed.
1 establishment unit
ENDODERM
since 20162.254.101.143
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52051A0624/00L000 | Wallonia | 109 m² | 1 · 114 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
984500D9D3BA55314923
Similar companies · same sector, comparable size
Dr. Ann Vandenbroucke
BE 0878.156.044
Jabbeke · Eq €518,728
Dr. Helena Devos
BE 0539.830.338
Merelbeke-Melle · Eq €519,279
OCULUS OOGARTSEN
BE 0787.990.584
Ieper · Eq €519,296
DR. HEYSE ALEX, CARDIOLOOG
BE 0844.778.047
Kluisbergen · Eq €518,535
HASTACA
BE 0822.164.179
Westerlo · Eq €518,472
Of 16,631 companies in sector 86220 we hold annual accounts for 7,985. 6,412 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded06-06-2016
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0655942209
Also
9925:BE0655942209
Registered
28-02-2026
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.